When a cancer diagnosis arrives outside the United States, two questions tend to surface almost immediately: is this the right treatment plan, and is there a more specialized opinion available somewhere else. For patients across Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, Iraq, and Mauritius, “somewhere else” often means an American academic cancer center. A third question usually follows close behind: how does a family access that expertise without flying everyone to Houston, Boston, or Tampa for weeks at a time.
That question has a more workable answer today than it did even five years ago. Travel, lodging, lost income, and visa logistics for an in-person international consultation stack directly on top of that burden, before treatment has even begun. For a meaningful share of families, remote access to a US specialist is not a workaround; it is the only realistic way to bring that expertise into the room at all.
This article looks at what a genuine cancer expert consultation from the US actually involves, what it costs at several well-known centers, and how a structured remote process, the model used by platforms such as Arbuda, makes that access more reachable for patients who are not travelling to the United States before a treatment decision is made.
What a Cancer Expert Consultation Actually Involves
A cancer expert consultation, sometimes called a second opinion, is a review of a diagnosis and proposed treatment plan by an independent physician or specialist team. Patients typically send their pathology report, imaging, and treatment history to a second physician or a multidisciplinary tumor board made up of surgeons, medical oncologists, radiation oncologists, and pathologists, who then communicate their findings back to the patient and the treating doctor.
Two things about that definition matter for anyone looking at this from outside the US. First, a second opinion adds to a patient's care rather than replacing it, the treating oncologist stays involved, and the specialist's findings are meant to inform that relationship, not sever it.
Second, the review is built almost entirely from documents: films, slides, lab values, and notes, not a physical exam in most cases. That is what makes a remote version of this process medically coherent rather than a lesser substitute, the substance of a second opinion has always been paperwork and pixels.
Arbuda's own service is built around this same distinction. Rather than providing second opinion service that challenges a local doctor's judgment, it provides Expert Opinion layer that adds subspecialist input (medical oncology, surgical oncology, radiation oncology, pathology, radiology) to a patient's existing oncology team, with recommendations shared back to the patient's own physician, who continues to lead the care plan.
Why Seeking an Online Cancer Second Opinion Matters
A second opinion from an independent cancer specialist can be crucial when facing major treatment decisions. Cancer treatment plans, whether involving chemotherapy, radiation, immunotherapy, or surgery, carry significant risks and benefits that deserve thorough evaluation from multiple expert perspectives. Studies published in The Lancet Oncology highlight that second opinions often lead to changes in diagnosis clarity, treatment selection, or staging information, resulting in better outcomes for patients. When you consult an online cancer specialist, you gain access to a physician who is not invested in your local healthcare system and can offer objective, evidence-based recommendations. This is especially valuable for rare cancer types, advanced stages, or when you feel uncertain about your current treatment plan. A second opinion also empowers you with knowledge, helping you make informed decisions that align with your health values and life circumstances.
What a US Cancer Expert Consultation Actually Costs
These are self-pay fees published directly by each institution as of 2026:
| Institution | Consultation format | Published starting price |
|---|---|---|
| Stanford Health Care | Online second opinion | $975 |
| Moffitt Cancer Center | Online consult (int'l patients) | From $2,500 |
| Dana-Farber Cancer Institute | Online second opinion | $3,000 |
| Cleveland Clinic | Virtual second opinion (int'l) | $4,500 |
Most of these institutions note that standard US health insurance rarely covers an online second opinion, though HSA or FSA funds can sometimes be applied. What the published fee does not include is everything that surrounds an in-person trip: flights for the patient and often a companion, a multi-week visa process, hotel stays near the hospital, and time away from work, costs that never appear on a price list but are very real for a family weighing their options.
Moreover, the total cost of “seeing a US specialist” can shift depending on whether the visit happens on a screen or requires a plane ticket. This is the gap a remote, coordinated expert opinion is built to close: the consultation fee stays close to what the hospital itself charges, and the travel-related costs simply do not apply.
Why Patients From the Gulf, Iraq, and Mauritius Look Beyond Their Borders
The reasons patients from these countries request a US-based opinion are rarely about the quality of care at home in the abstract. They tend to be specific: a rare cancer subtype with limited local case volume, a treatment plan the family wants reviewed before committing to it, or a diagnosis where guidance from two local providers has conflicted.
WHO's 2026 report notes that access to sub-specialized cancer expertise and advanced diagnostics remains unevenly distributed worldwide, precisely the gap an expert opinion from a high-volume academic center is designed to help close, without requiring a change of country for treatment.
For patients based in Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, Iraq, and Mauritius specifically, the practical barriers to an in-person US consultation are real: visa appointment wait times, the cost of extended-stay lodging near a cancer center, and the disruption of pulling a patient, often mid-treatment, out of their home care setting. A remote consultation removes the travel barrier while leaving the clinical question intact.
How a Remote Cancer Expert Consultation Works, Step by Step
The mechanics are broadly consistent across the institutions referenced above, and across coordination platforms like Arbuda:
-
Records collection. Pathology slides or digital pathology images, radiology films (CT, MRI, PET), a full treatment history, and current medication list are gathered from the patient's local hospital.
-
Case submission. Records are uploaded to a secure platform, along with the specific clinical questions the patient and their local doctor want addressed.
-
Specialist assignment. A subspecialist matched to the exact cancer type and stage, not a generalist, is assigned to review the case, often alongside a multidisciplinary tumor board.
-
Review and written opinion. The specialist evaluates the pathology, imaging, and treatment plan and prepares a written report. Dana-Farber, for example, states a completed review typically takes 7 to 14 business days once records are in hand.
-
Delivery to patient and local physician. The report goes to both the patient and their treating doctor, who decide together how to apply it to the existing plan.
Nowhere in this sequence does the patient need to be physically present in the United States. That single fact is what makes remote expert opinion programs a legitimate, and often more practical, entry point than an in-person visit for many international families.
What to Prepare Before You Request One
Cancer centers and coordination platforms alike ask for a fairly consistent set of documents, and having them ready shortens the timeline considerably:
-
Pathology report and, where possible, physical slides or a digital scan
-
Imaging studies in DICOM format (CT, MRI, PET, ultrasound), not just written radiology reports
-
A written summary of treatment received so far, including drug names, doses, and dates
-
Current medication list and known allergies
-
Two or three specific questions the family wants the specialist to answer
Case managers at both hospital programs and Arbuda typically handle the back-and-forth of chasing down missing records from local providers, which is often the single biggest source of delay in this process.
Where Arbuda Fits Into This
Here is the practical version of how this looks if a patient in the Gulf, Iraq, or Mauritius chooses to go through Arbuda specifically, rather than approaching a US hospital's international office directly.
Arbuda is not a hospital, and it does not provide medical treatment. It is a technology-enabled patient navigation platform that coordinates access to US oncology specialists for expert opinion. In practice, that coordination work breaks down into a few distinct pieces, each addressing a different point where international patients usually get stuck.
Expert Opinion Review
This is the core service and the one most families start with: a full multidisciplinary review of a diagnosis and proposed treatment plan, drawing on medical oncology, surgical oncology, radiation oncology, pathology, and radiology as the specific case requires. The goal is a second, subspecialist-level set of eyes on a treatment decision before a family commits to it, not a directive to change course.
-
Pathology, imaging, and treatment history collected and organized from the patient's local hospital
-
Case matched to a subspecialist in the relevant cancer type and stage, with a multidisciplinary tumor board where the case calls for it
-
Written recommendations shared with both the patient and their treating oncologist
-
No requirement to switch hospitals or physicians in order to request a review.
Pathology Second Opinion
Treatment planning starts with an accurate diagnosis, which is why a pathology-focused review is often the first service a family uses. Slides or digital pathology images are re-examined independently by a US-based pathologist, most relevant when a cancer subtype is rare or borderline, or when two local pathology reports do not agree.
-
Digital pathology slides reviewed independently of the original reading
-
Particularly useful for rare, unusual, or ambiguous cancer subtypes
-
Findings sent back to the local pathologist and treating physician for direct comparison.
Treatment & Care Coordination Support
For a smaller number of cases, an expert opinion points to a next step, an advanced procedure, a clinical trial, or a subspecialist not available locally, that the family wants to explore further. Here, Arbuda's role shifts from opinion coordination to logistics support, helping the patient and their local physician understand what pursuing that next step at a US center would actually involve.
-
Identifying centers or specialists relevant to a specific recommendation
-
Coordinating records and communication between local and US-based providers
-
Supporting the practical planning around a possible in-person visit, if and when the family chooses to pursue one.
Across all three services, Arbuda offers a layer of subspecialist expertise to a patient's existing oncology team, not as a competing opinion meant to replace the local doctor, and the coordination work is built specifically around the logistics that trip up international patients, collecting records across languages and hospital systems, formatting imaging so a US specialist can actually read it, and keeping a case moving instead of stalling in an inbox.
Arbuda USA specifically serves patients in Saudi Arabia, the UAE, Qatar, Kuwait, Oman, Bahrain, Iraq, and Mauritius who want access to US medical specialists through online consultation and treatment guidance, without relocating for care. If, after an expert opinion, a family decides that treatment at a US center makes sense, that is a separate and later decision, the consultation itself is not designed to fast-track a transfer, and no timeline or outcome is promised at the outset.
Questions Worth Asking Before You Choose a Remote Consultation Service
Not every “expert opinion” service is structured the same way, and a few questions tend to separate a credible program from a vague one:
- Which physicians review the case, and what are their current academic or hospital affiliations?
- Is the fee all-inclusive, or are there additional charges for pathology re-review or extra imaging?
- What is the expected turnaround time once records are complete?
- Who owns the medical records after the review, and how is patient data protected in transit and storage?
- Does the service explicitly state that it does not replace the patient's treating physician?
A program that cannot answer these clearly is worth treating with caution, regardless of which country it is based in.
Conclusion
Getting a cancer diagnosis reviewed by a US specialist does not require a passport, a visa appointment, or weeks away from home. It requires complete records, a clear clinical question, and a structured process that connects the patient's local doctor with the right subspecialist. The consultation fees published by major US cancer centers, from roughly $975 to $4,500, are only part of the real cost of getting a US opinion; the travel and logistics around an in-person visit are usually the larger burden, and they are also the part a remote, coordinated expert opinion removes entirely. For patients in the Gulf, Iraq, and Mauritius weighing this route, the more useful question is rarely “should we go to America,” but “how do we get the right specialist's eyes on this file as quickly and completely as possible”, and for a growing number of families, that answer no longer involves a flight.
Chat with the Arbuda assistant to talk through what records you'd need and how the Expert Opinion process would work for your case, no cost or obligation to proceed.
Medical Disclaimer: This article is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for professional medical consultation. Arbuda does not provide medical treatment and does not replace a patient's relationship with their treating physician. Always consult a qualified healthcare provider with questions about a specific diagnosis or treatment plan. Pricing information reflects publicly available figures as of 2026 and is subject to change; readers should confirm current pricing directly with each institution.
